After Completing the Registration Process, your Biography will be displayed here.
Register by using your Entry ID: 26055
Register by using your Entry ID: 26055
Bashar Ibrahim's academic journey began with a Bachelor's degree in Microbiology from Mosul University, awarded on August 2, 2003. His deep interest in medical microbiology led him to pursue a Master's degree at Gazi University, where he completed his thesis titled "Allojenik nakil olan akut lösemili hastalarda nakil öncesi ve sonrası HEV prevalansı" under the supervision of Gülendam Bozdayı in February 2011. Furthering his scholarly pursuits, he earned a Ph.D. in Medical Microbiology (Medicine) from Eskisehir Osmangazi University in June 2016, where he conducted in-depth research on the prevalence of Campylobacter jejuni in infectious diarrheas under the guidance of Gül Durmaz.
Dr. Bashar Ibrahim currently serves as an Assistant Professor in the Department of Pharmaceutical Microbiology at the Faculty of Pharmacy, Suleyman Demirel University, since January 11, 2020. His academic career reflects a robust engagement with the field of medical microbiology, particularly with a pharmaceutical application focus. He plays a vital role not just in academia but also in research project development and scientific collaborations at both national and international levels.
His research spans infectious diseases, clinical virology, parasitology, vaccines, and the rational use of antimicrobials. His doctoral and master's theses underscore a sustained focus on pathogen prevalence in clinical settings, notably HEV in leukemia patients undergoing transplantation and Campylobacter jejuni in gastrointestinal infections. Dr. Ibrahim is also actively involved in a TÜBİTAK 1507 KOBİ R&D project supporting pharmaceutical innovation, where he serves as a researcher, collaborating with Principal Investigator Ahmet Arif Kurt since September 15, 2024.
In recognition of his contributions to the field, Dr. Ibrahim was honored with the Science Honor Award (Bilim Onur Ödülü) by the International Academy of Sciences in 2020. This prestigious accolade affirms his influence in the field of pharmaceutical microbiology and the broader scientific community.
While citation databases and publication specifics are not listed here, Dr. Ibrahim’s award-winning recognition and project involvement suggest active engagement with peer-reviewed scientific literature. Further details on his citation metrics, h-index, or Scopus/Google Scholar profiles would enrich this section upon availability.
Dr. Ibrahim possesses technical expertise in microbial diagnostics, clinical microbiology, virology, sterility assurance, vaccine development, immunology lab techniques, and parasitology testing. His training spans complex laboratory methodologies used in infectious disease monitoring, sterile pharmaceutical practices, and antimicrobial resistance assessment.
With a strong commitment to education, Dr. Ibrahim has designed and delivered a range of undergraduate courses at Suleyman Demirel University. These include:
Infectious Diseases (Spring 2024–2025)
Vaccines (Spring 2024–2025 and 2022–2023)
Sterility, Hygiene and Asepsis in Pharmacy (Fall 2023–2024)
Antimicrobials and Rational Use (Fall 2023–2024)
Pharmaceutical Microbiology & Immunology Lab (Fall 2023–2024 and 2022–2023)
Clinical Microbiology and Medical Virology (Spring and Fall 2022–2023)
Medical Parasitology (Fall 2023–2024)
These courses, delivered in Turkish, reflect his multidisciplinary approach and dedication to practical, lab-based learning integrated with theoretical microbiological principles.
Dr. Bashar Ibrahim continues to contribute meaningfully to the future of pharmaceutical microbiology through teaching, research, and applied science collaboration. His involvement in national-level R&D, especially within TÜBİTAK’s innovation-driven ecosystem, signals a commitment to bridging academic knowledge with real-world pharmaceutical applications. His trajectory suggests increasing influence in both academic mentoring and health sciences policy research, particularly in Turkey and the broader scientific arena.
Authors: Ali Öztürk, Taylan Bozok, Merve Erdoğan, Bashar M.S. Ibrahim, Tugce Simsek Bozok
Journal: Folia Microbiologica
Year: Published online June 9, 2023 pubmed.ncbi.nlm.nih.gov+10scienceopen.com+10ouci.dntb.gov.ua+10
Authors: Bashar İbrahim, Gül Durmaz, Mehdi Meskini Heydarlou
Journal: Osmangazi Tıp Dergisi (Osmangazi Journal of Medicine)
Year: 2020 turkmedline.net+3researchgate.net+3dergipark.org.tr+3
Authors: Ahmet Arif Kurt, Bashar Ibrahim
Journal: Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
Year: 2024 dergipark.org.tr
Authors: Ahmet Arif Kurt, Bashar İbrahim
Journal: Journal of Immunology and Clinical Microbiology
Year: 2024 ouci.dntb.gov.ua+12dergipark.org.tr+12scholar.google.com+12
Authors: Bashar İbrahim, Ahmet Arif Kurt
Journal: Journal of Immunology and Clinical Microbiology
Year: 2024
Federal Ministry of Health, Nigeria.
Dr. Solomon Monday Jacob (JSM) is a seasoned Medical Parasitologist and a Chief Medical Laboratory Scientist at the Federal Ministry of Health, Nigeria. He serves as the Technical Lead for the National Schistosomiasis and Soil-Transmitted Helminthiasis Control Programme, playing a pivotal role in expanding Neglected Tropical Diseases (NTDs) control in Nigeria. With vast experience in malaria, onchocerciasis, lymphatic filariasis, and NTD research, he has contributed significantly to disease prevention strategies. He has published numerous research papers and collaborates with global organizations on healthcare innovations.
Dr. Solomon Jacob holds a PhD in Medical Laboratory Science with a specialization in Medical Parasitology. His academic journey has equipped him with in-depth knowledge of infectious diseases, epidemiology, and diagnostic techniques. In addition to his doctorate, he has undergone extensive training in Neglected Tropical Diseases (NTD) control programs, focusing on strategies for disease surveillance, prevention, and treatment. His expertise in disease epidemiology has enabled him to contribute significantly to public health initiatives, research projects, and policy development aimed at reducing the burden of NTDs in Nigeria and beyond.
Dr. Solomon Jacob is a dedicated Program Officer for Neglected Tropical Diseases (NTDs) at the Federal Ministry of Health, Nigeria, where he plays a crucial role in formulating and implementing national disease control strategies. As a Chief Medical Laboratory Scientist, he leads technical initiatives for the Schistosomiasis & Soil-Transmitted Helminthiasis Control Programme, focusing on innovative approaches to diagnosis, treatment, and eradication efforts.
Beyond his government role, Dr. Jacob serves as a Researcher and Consultant, contributing to significant projects on Malaria, Onchocerciasis, Lymphatic Filariasis, and other NTDs. His work involves operational research, policy advisory, and capacity building to strengthen disease surveillance and control measures. Additionally, he is an Editorial Board Member for renowned scientific journals such as PLoS NTD and Elsevier, furthering his impact in global health research.
Neglected Tropical Diseases (NTDs) 🦠
Schistosomiasis & Soil-Transmitted Helminthiasis 🏥
Malaria & Vector-Borne Diseases 🦟
Onchocerciasis & Lymphatic Filariasis 🏨
Public Health & Disease Control Strategies
Recognized for strategic contributions to NTD control in Nigeria
Lead researcher in multiple operational health projects
Editorial Appointments with PLoS NTD, Elsevier
Schistosomiasis and Soil Transmitted Helminthiasis Among School-Age Children: Impact of 3–5 Annual Rounds of Mass Drug Administration in Ekiti State, Southwest Nigeria
🗓 2025-03-23 | Journal article | 📖 Tropical Medicine and Infectious Disease
🔗 DOI: 10.3390/tropicalmed10040085
👥 Contributors: Solomon Monday Jacob, Jan-Carel Diehl, Gleb Vdovine, Temitope Agbana, Samuel Popoola, Satyajith Jujjavarapu, David Bell, Akande Oladimeji Ajayi, Joseph O. Fadare, Adebowale F. Akinwumi et al.
Impact of Preventive Chemotherapy on the Prevalence of Schistosomiasis and Soil-Transmitted Helminthiasis Among School-Age Children After 3–5 Effective Rounds of Annual Mass Drug Administration in Ekiti State, Southwest Nigeria
🗓 2025-01-27 | Preprint
🔗 DOI: 10.20944/preprints202501.1916.v1
👥 Contributors: Solomon Monday Jacob, Jan-Carel Diehl, Gleb Vdovine, Temitope Agbana, Samuel Popoola, Satyajith Jujjavarapu, David Bell, Oladimeji Ajayi, Joseph O. Fadare, Adebowale F. Akinwumi et al.
Impact of Praziquantel Mass Drug Administration after Several Rounds on Schistosomiasis Among School-Aged Children in Abuja, Nigeria
🗓 2025-01-22 | Preprint
🔗 DOI: 10.20944/preprints202501.1625.v1
👥 Contributors: Solomon Monday Jacob, Sophie Y. Akinbo, Akinola Stephen Oluwole, Temitope Agbana, Zainab Omoruyi, Michael A. Okungbowa, Diehl Jan-Carel, Fredrick O. Akinbo
Community Mobilisation for Human Sample Collection in Sensitive Communities: Experiences from Granular Mapping of Schistosomiasis and Soil-Transmitted Helminths in Ekiti State, South West, Nigeria
🗓 2024-10-25 | Journal article | 📖 Tropical Medicine and Infectious Disease
🔗 DOI: 10.3390/tropicalmed9110255
👥 Contributors: Temitope Agbana, Omolade Omotade, Moses Aderogba, David Bell, Jacob Solomon, Saheed Animashaun, Peace Alabi, Oladimeji Ajayi, Adebowale Akinwumi, Samuel Popoola et al.
Community Mobilisation for Human Sample Collection in Sensitive Communities: Experiences from Granular Mapping of Schistosomiasis & Soil-Transmitted Helminths in Ekiti State, Nigeria
🗓 2024-09-16 | Preprint
🔗 DOI: 10.20944/preprints202409.1200.v1
👥 Contributors: Temitope Agbana, Omolade Omotade, Moses Aderogba, David Bell, Jacob Solomon, Saheed Animashaun, Peace Alabi, Oladimeji Ajayi, Adebowale Akinwumi, Samuel Popoola et al.